157 Clinicopathological implications of cyclin B1, cdc2, p16 and p53 expression in breast cancer

J.H.Kim; D.H.Kim; S.W.Chae; J.H.Sohn; C.K.Yom; S.Y.Kim; Y.L.Park

首页> 外文期刊>European Journal of Cancer Supplements >157 Clinicopathological implications of cyclin B1, cdc2, p16 and p53 expression in breast cancer

【24h】

157 Clinicopathological implications of cyclin B1, cdc2, p16 and p53 expression in breast cancer

机译：157乳腺癌中细胞周期蛋白B1，cdc2，p16和p53表达的临床病理意义

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements 》 |2010年第3期| 共1页
作者
J.H.Kim; D.H.Kim; S.W.Chae; J.H.Sohn; C.K.Yom; S.Y.Kim; Y.L.Park;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Overexpressions of Cyclin B1, cdc2, p16 and p53 in Human Breast Cancer: The Clinicopathologic Correlations and Prognostic Implications [J] . Chae Seoung Wan, Sohn Jin Hee, Kim Dong-Hoon, Yonsei Medical Journal . 2011 ,第3期

机译：细胞周期蛋白B1，cdc2，p16和p53在乳腺癌中的过表达：临床病理相关性和预后意义。
2. Low Expression of p27 Protein Combined with Altered p53 and Rb|[sol]|p16 Expression Status Is Associated with Increased Expression of Cyclin A and Cyclin B1 in Diffuse Large B-Cell Lymphomas [J] . Maria Bai, John Vlachonikolis, Niki J Agnantis, Modern Pathology . 2001 ,第11期

机译：p27蛋白的低表达与改变的p53和Rb | [sol] | p16表达状态相关，与弥漫性大B细胞淋巴瘤中cyclin A和cyclin B1表达的增加有关
3. 12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells. [J] . Kim S, Lee HS, Lee SK, Phytomedicine : . 2010 ,第14期

机译：通过硅蛋白通过细胞周期蛋白B1和CDC2的下调和MDA-MB231人乳腺癌细胞P21表达的上调，通过硅蛋白增加了12-O-四癸酰苯甲酸博博-13-醋酸（TPA）诱导的生长停滞。
4. Clinical implications of HER-2 and p53 in taxane-based and anthracycline-based neoadjuvant chemotherapy in breast cancer [C] . World congress on breast diseases . 2008

机译：HER-2和P53在紫杉烷基和蒽环类新辅助化疗的乳腺癌中的临床意义
5. p53- and p73-mediated transcriptional repression of the cyclin B1 promoter is dependent on functional Sp1 DNA binding sites. [D] . Innocente, Steven A. 2005

机译：细胞周期蛋白B1启动子的p53和p73介导的转录抑制取决于功能性Sp1 DNA结合位点。
6. Overexpressions of Cyclin B1 cdc2 p16 and p53 in Human Breast Cancer: The Clinicopathologic Correlations and Prognostic Implications [O] . Seoung Wan Chae, Jin Hee Sohn, Dong-Hoon Kim, 2011

机译：细胞周期蛋白B1cdc2p16和p53在乳腺癌中的过表达：临床病理相关性和预后意义。
7. Overexpressions of Cyclin B1, cdc2, p16 and p53 in Human Breast Cancer: The Clinicopathologic Correlations and Prognostic Implications [O] . Chae, Seoung Wan, Sohn, Jin Hee, Kim, Dong-Hoon, 2011

机译：细胞周期蛋白B1，cdc2，p16和p53在乳腺癌中的过表达：临床病理相关性和预后意义。
8. Cohort Study of the Relationship Between c-erbB-2 and Cyclin D1 Overexpression, p53 Mutation and/or Protein Accumulation, and Risk of Progression from Benign Breast Disease to Breast Cancer; and Creation of a Bank of Benign Breast Tissue [R] . Kandel, R. A. , Rohan, T. 2002

机译：队列研究c-erbB-2和细胞周期蛋白D1过表达，p53突变和/或蛋白质积累，以及从良性乳腺疾病进展到乳腺癌的风险;和创建良性乳腺组织

157 Clinicopathological implications of cyclin B1, cdc2, p16 and p53 expression in breast cancer

著录项

相似文献

相关主题

期刊订阅